Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Christoph Blohmke

Academic visitor


Christoph Blohmke obtained his PhD in Experimental Medicine from the University of British Columbia, Canada. In his PhD he studied the host-pathogen interaction in Cystic Fibrosis lung disease to understand the pulmonary innate immune system in order to identify novel targets for anti-inflammatory therapy. Prior to moving to Canada, he graduated from the University of Lubeck with a BSc in Molecular Biotechnology before completing an MSc program in Medical Biochemistry at the University of Amsterdam. He joined the Oxford Vaccine Group in October 2011 to study the human immune response to S. Typhi.